Last updated 2026-07-27
- Went public on NASDAQ (MBOT), Mar 1992
- Acquired NitiLoop, Oct 2022
- Acquired CardioSert for $370k, May 2018
Total raised
$503.3M
Last: Public Offering 2025-10
Stage
Public
Founded
2010
Headcount
56
HQ
Hingham, United States
Sector
Health Tech & Life Sciences
About
Microbot Medical Inc. is a medical device company focused on transforming endovascular procedures through advanced robotic technology. The company specializes in the research, design, development, and commercialization of transformational micro-robotics medical technologies, leveraging natural and artificial lumens within the human body. Its flagship product, the LIBERTY® Endovascular Robotic System, is the first single-use, remotely operated robotic solution designed for precision, efficiency, and provider safety in various endovascular interventional procedures. Microbot Medical also has other technological platforms like ViRob™ and TipCAT™ and is developing products such as the Self Cleaning Shunt (SCS™) for hydrocephalus. The company operates in the US and Israel.
Funding history · 41 rounds · $503.3M total
2026-04
Follow-on PO
$39.2M
2025-10
PIPE
$2.8M
2025-09
PIPE
$29.7M
2025-08
PIPE
$7.6M
2025-04
PIPE
$2.3M
2025-02
Follow-on PO
$15.6M
2025-02
PIPE
$13.0M
2025-01
Follow-on PO
$7.0M
2024-06
PIPE
$2.4M
2024-01
Follow-on PO
$2.7M
2023-06
Grant
Undisclosed
2023-05
PIPE
$1.4M
2022-10
Follow-on PO
$5.0M
2021-06
Follow-on PO
$10.0M
2019-12
PIPE
$9.6M
2019-01
Follow-on PO
$3.0M
2019-01
PIPE
$5.9M
2019-01
PIPE
$2.5M
2017-06
Follow-on PO
$10.1M
2017-01
Follow-on PO
$3.5M
2016-08
Debt Financing
$2.0M
2016-03
Follow-on PO
$8.0M
2015-04
Follow-on PO
$25.0M
2014-07
Follow-on PO
$20.0M
2014-02
Follow-on PO
$27.0M
2013-10
Follow-on PO
$16.2M
2012-12
Follow-on PO
$30.0M
2011-12
Follow-on PO
$10.0M
2011-10
Follow-on PO
$30.0M
2011-01
Follow-on PO
$16.0M
2010-06
Follow-on PO
$10.4M
2009-10
Follow-on PO
$12.5M
2009-06
Follow-on PO
$30.0M
2008-07
Follow-on PO
$20.0M
2006-12
Follow-on PO
Undisclosed
2006-04
Follow-on PO
$35.8M
2004-10
Follow-on PO
$22.5M
2003-12
Follow-on PO
$9.5M
2003-01
Follow-on PO
Undisclosed
2002-08
Follow-on PO
$1.1M
2001-08
IPO
$4.0M
Headcount over time
From 13 (2018-08) to 44 (2026-03) · +31 (+238%) · 37 points · source: Finder history + radar grounding
Q&A
- What significant regulatory milestone did Microbot Medical achieve in September 2025?
- In September 2025, Microbot Medical Inc. received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, allowing commercialization in the U.S. market.
- What was the outcome of Microbot Medical's pivotal human clinical trial for the LIBERTY Endovascular Robotic Surgical System?
- In October 2024, Microbot Medical announced the successful completion of its pivotal human clinical trial for the LIBERTY Endovascular Robotic Surgical System, accelerating its go-to-market strategy for a Q2 2025 commercial launch.
- What strategic partnership did Microbot Medical form in August 2024 to advance telesurgery?
- In August 2024, Microbot Medical Inc. signed a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using the LIBERTY Endovascular Robotic System.
- What quality certification did Microbot Medical receive in August 2024?
- In August 2024, Microbot Medical Inc. received ISO 13485:2016 certification for its quality management system, a crucial step for commercialization and regulatory compliance in the EU and US.
- What was the outcome of Microbot Medical's GLP pivotal pre-clinical study for the LIBERTY Endovascular Robotic Surgical System in December 2023?
- In December 2023, Microbot Medical Inc. successfully completed its GLP pivotal pre-clinical study for the LIBERTY Endovascular Robotic Surgical System, meeting all study objectives and paving the way for human clinical trials.
- What was the purpose of Microbot Medical's manufacturing agreement with B.Y. Medimor Ltd. in August 2023?
- In August 2023, Microbot Medical Inc. signed a manufacturing agreement with B.Y. Medimor Ltd. for the production of its LIBERTY Robotic Surgical System, supporting its transition to clinical trials and commercialization.
- What was the outcome of Microbot Medical's extended pre-clinical animal study for the LIBERTY Surgical Robotic System in May 2023?
- In May 2023, Microbot Medical Inc. achieved a 100% success rate in an extended joint pre-clinical animal study for its LIBERTY Surgical Robotic System, with six European interventional radiologists performing 48 catheterizations.
- What was the impact of Microbot Medical's Core Business Focus Program and cost restructuring plan announced in May 2023?
- In May 2023, Microbot Medical Inc. announced a Core Business Focus Program and cost restructuring plan to prioritize its LIBERTY Robotic Surgical System, which involved eliminating non-core technology expenses and reducing positions not directly supporting the core technology.
- What was the total amount raised by Microbot Medical through four recent registered direct offerings by June 2023?
- By June 2023, Microbot Medical Inc. raised a total of approximately $7.6 million in gross proceeds from four recent registered direct offerings.
- What was the purpose of the $440,000 grant Microbot Medical received in June 2023?
- In June 2023, Microbot Medical Inc. received a $440,000 grant to support the development of the manufacturing process for its endovascular surgical robotic system.
Team · 3
Harel Gadot
Founder · Co-founder
Moshe Shoham
Founder · Co-founder
Yossi Bornstein
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
gastroenterologyvascularroboticsminimally-invasiveneurologyendoscopycolonoscopyurologydrug-deliveryimagingmedical-deviceshospitalsdoctorsoptronicsneurovascularmedical-equipmenttelemedicinemedical-technologiescardiovascular
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | microbotmedical.com |
|---|---|
| linkedin.com/company/1502003 | |
| facebook.com/microbotmedical | |
| YouTube | youtube.com/channel/UCXvfiDfCv_R5mDSiyEacsvg |
Identifiers & details
| Founded | 2010 |
|---|---|
| Employees (exact) | 56 |
| Offices | Braintree |
| Market cap | $134.3M |
| Status reason | Public on NASDAQ on Nov 2016; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| NitiLoop | 2022-10 | |
| CardioSert | 2018-05 | $370K |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 1992-03 | NASDAQ | MBOT | |
| Registered Direct Offering | 2019-01 | NASDAQ | MBOT | $2.5M |
| Registered Direct Offering | 2024-06 | NASDAQ | MBOT | $2.4M |
| Registered Direct Offering | 2025-01 | NASDAQ | MBOT | $11.8M |
| Stock Issuance | 2025-08 | NASDAQ | MBOT | $8.6M |
| Follow-on Offering | 2025-09 | NASDAQ | MBOT | $25.2M |
| Follow-on Offering | 2025-10 | NASDAQ | MBOT | $29.2M |
Radar intelligence
Patents
| EPO | 20 |
|---|
Web history (Wayback)
| Domain | microbotmedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 17 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514519412 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-11-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 5 — annual_report (4), charge (1) |
| Registered address | היזמה 6 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-20 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2025-10-20 | דו~ח שנתי-הוספת בעל תפקיד |
| 2025-10-20 | דו~ח שנתי-הסרת בעל תפקיד |
| 2025-10-20 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-02-02 | רישום שעבוד |